Joseph Surber, DO
Family Medicine · Columbus, GANPI 1598814246
Payments from drug & device makers
Across 4,234 payments — averaging $3916.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$7.4M
- Pfizer$3.7M
- Merck$956K
- Bavarian Nordic A/s$819K
- Regeneron$799K
- Janssen Research & Development, LLC$645K
- plus $2.3M from 19 others
Across 21 payments — averaging $6625.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- First Wave Biopharma, Inc.$79K
- Eli Lilly$58K
- AbbVie$2K
What the payments were for
- Speaking & faculty fees$1502%
- Travel & lodging$5,81871%
- Food & beverage$2,22227%
- Education$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 2,772 | $7,384,458 |
| Pfizer | 214 | $3,679,980 |
| Merck | 23 | $956,024 |
| Bavarian Nordic A/s | 133 | $818,913 |
| Regeneron | 96 | $798,844 |
| Janssen Research & Development, LLC | 357 | $644,546 |
| GSK | 82 | $449,668 |
| Roche Diagnostics Operations, Inc. | 37 | $399,679 |
| Genentech, Inc. | 53 | $386,440 |
| Novavax Inc | 17 | $258,643 |
| Sanofi Pasteur Inc. | 12 | $255,093 |
| Boehringer Ingelheim | 31 | $203,919 |
| Seqirus USA Inc | 41 | $75,005 |
| Novo Nordisk AS | 189 | $57,654 |
| Bayer | 28 | $45,303 |
| Novartis | 2 | $36,593 |
| Eli Lilly | 12 | $31,340 |
| AstraZeneca | 15 | $21,863 |
| Alnylam Pharmaceuticals Inc. | 4 | $17,848 |
| Boehringer Ingelheim International GmbH | 101 | $16,389 |
| Hoffmann-la Roche Limited | 4 | $15,751 |
| Verona Pharma, Inc. | 2 | $15,600 |
| Sanofi US Services Inc. | 6 | $7,235 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $6,700 |
| Sanofi-aventis U.S. LLC | 1 | $150 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,583,640 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Columbus
- Jeffrey KingsleyColumbus$8.1M
- Bantwal BaligaColumbus$117K
- Megbewe OkorobaColumbus$61K
- Kimberly Brown-GullattColumbus$35K
- Angela RitterGainesville$15.8M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.